The biological activity of 70% ~ 95% of the total TNF activity exerted by TNF-α [27, 30] and previous studies have suggested that TNF-α can be used to treat soft tissue sarcomas and metastatic melanoma [28, 31]. This evidence concerns the gene TNF and metastatic melanoma.